In both instances, the goal of organ protection with SGLT2i or GLP-1 RA should be independent of background glucose-lowering therapies, current HbA 1c level or target HbA 1c level (Figs 3, 4)
Most of the studies have been done on rats, and its not clear if the benefits apply to humans
However, only decreasing trend in triglyceride was found in between-group comparison
On the basis of various factors, such as the concentration of active ingredients or the patient's condition, the combination according to the invention can be marketed as a food supplement, a nutritional supplement, or as a therapeutic product on sale with or without a compulsory doctor's prescription
For people with diabetes, too much sugar is already in the blood
The new approach is more surgical